Microscopic scaffolding offers a 'simple' solution to treating skin injuries

Jun 28, 2006

A revolutionary dissolvable scaffold for growing new areas of skin could provide a safer, more effective way of treating burns, diabetic ulcers and similar injuries.

This ultra-fine, 3-dimensional scaffold, which is made from specially developed polymers, looks similar to tissue paper but has fibres 100 times finer. Before it is placed over a wound, the patient's skin cells (obtained via a biopsy) are introduced and attach themselves to the scaffold, multiplying until they eventually grow over it. When placed over the wound, the scaffold dissolves harmlessly over 6 to 8 weeks, leaving the patient's skin cells behind.

This new approach to skin reconstruction has been developed by a team of chemists, materials scientists and tissue engineers at the University of Sheffield, with funding from the Engineering and Physical Sciences Research Council. It is designed primarily for cases involving extensive burns where surgeons are unable to take enough skin grafts from elsewhere on the body to cover the damaged areas. Currently, bovine collagen or skin from human donors is used in these cases, but these approaches have potential health and rejection risks.

"Simplicity is the key," says Professor Tony Ryan, who is leading the team. "Previous attempts to find better ways of encouraging skin cell growth have used chemical additives and other elaborate techniques to produce scaffolds, but their success has been limited. We've found that skin cells are actually very 'smart' – it's in their DNA to sort themselves into the right arrangement. They just need a comparatively uncomplicated scaffold (and each other) to help them grow in a safe, natural way."

The polymers used in the scaffold are biodegradable materials already approved for medical applications. Because the team has recognised that skin cells are 'smart' and the scaffold can therefore be 'dumb' (i.e. not overly sophisticated), simple polymers can be used.

The process for making the scaffolds is based on the well-known technique of electrospinning. However, the team has made a key advance by developing a new method of making, from the same biodegradable polymers, aligned-fibre 'mats' of potential use in promoting nerve or tendon growth. This method is currently being patented.

The next step in the research is to develop the skin reconstruction technology for clinical use, hopefully in the next few years. The technology also offers possibilities for testing the toxicity of cosmetic and similar products, using materials grown in the laboratory that closely resemble natural skin.

"Ultimately, we can envisage treatment of burns victims and the undertaking of reconstructive surgery using the scaffold and the patient's own skin to produce bespoke skin for that patient," says Professor Ryan. "As an accident-prone mountain biker, I find that prospect very attractive!"

Source: Engineering and Physical Sciences Research Council

Explore further: Pancreatic cancer risk not higher with diabetes Rx DPP-4i

add to favorites email to friend print save as pdf

Related Stories

Tissue regeneration using anti-inflammatory nanomolecules

Aug 22, 2014

Anyone who has suffered an injury can probably remember the after-effects, including pain, swelling or redness. These are signs that the body is fighting back against the injury. When tissue in the body is damaged, biological ...

On the frontiers of cyborg science

Aug 10, 2014

No longer just fantastical fodder for sci-fi buffs, cyborg technology is bringing us tangible progress toward real-life electronic skin, prosthetics and ultraflexible circuits. Now taking this human-machine concept to an ...

Materials scientists turn to collagen

Jun 05, 2014

(Phys.org) —Miniature scaffolds made from collagen – the 'glue' that holds our bodies together – are being used to heal damaged joints, and could be used to develop new cancer therapies or help repair ...

Recommended for you

Pancreatic cancer risk not higher with diabetes Rx DPP-4i

37 minutes ago

(HealthDay)—There is no increased short-term pancreatic cancer risk with dipeptidyl-peptidase-4 inhibitors (DPP-4i) compared to sulfonylureas (SU) and thiazolidinediones (TZD) for glycemic control, according ...

Operative management of femoral neck Fx has changed

1 hour ago

(HealthDay)—Trends in operative management of femoral neck fractures by orthopedic surgeons applying for board certification have changed over time, according to research published in the Sept. 3 issue ...

User comments : 0